Atlas Trials

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Clinical trial NCT00445601 · COMPLETED

Trial details

NCT number
NCT00445601
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2007-09-01
Primary completion
2017-06-01
Enrollment
406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.